$2.21
-0.08 (-3.49%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,151.6% upside
Low Target
$20.34
Average Target
$27.66
High Target
$35.38
Current Price
$2.21
Current
$2.21
$2.21
Target
$27.66
$27.66
$20.34
$27.66 avg
$35.38
Scenario Analysis
Bear Case
$20.34
820.4%
Low target
Base Case
$27.66
+1,151.6%
Avg target
Bull Case
$35.38
+1,500.9%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$138.60
-98.4% from high
52-Week Low
$1.71
+29.2% from low
Target vs 52W High
$27.66
-80.0% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.5% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |